Literature DB >> 19527723

Physiological responses to protein aggregates: fibrinolysis, coagulation and inflammation (new roles for old factors).

Martijn F B G Gebbink1, Barend Bouma, Coen Maas, Bonno N Bouma.   

Abstract

Misfolding is an inherent and potentially problematic propensity of proteins. Misfolded proteins tend to aggregate and the deposition of aggregated proteins is associated with a variety of highly debilitating diseases known as amyloidoses. Protein misfolding and aggregation is also increasingly recognized as the underlying cause of other health problems, including atherosclerosis and immunogenicity of biopharmaceuticals. This raises the question how nature deals with the removal of obsolete proteins in order to avoid their accumulation and disease. In recent years two proteases, tPA and factor XII, have been identified that specifically recognize aggregates of misfolded proteins. We here review these discoveries that have uncovered new roles for the fibrinolytic system and the contact activation system beyond haemostasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19527723     DOI: 10.1016/j.febslet.2009.06.013

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  Arterial thrombus formation in cardiovascular disease.

Authors:  Giuseppe Lippi; Massimo Franchini; Giovanni Targher
Journal:  Nat Rev Cardiol       Date:  2011-07-05       Impact factor: 32.419

Review 2.  In vivo roles of factor XII.

Authors:  Thomas Renné; Alvin H Schmaier; Katrin F Nickel; Margareta Blombäck; Coen Maas
Journal:  Blood       Date:  2012-09-19       Impact factor: 22.113

3.  The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies.

Authors:  Colin Longstaff; Craig Thelwell; Stella C Williams; Marta M C G Silva; László Szabó; Krasimir Kolev
Journal:  Blood       Date:  2010-10-21       Impact factor: 22.113

4.  Effects of extracellular DNA on plasminogen activation and fibrinolysis.

Authors:  Andrey A Komissarov; Galina Florova; Steven Idell
Journal:  J Biol Chem       Date:  2011-10-05       Impact factor: 5.157

5.  The time course of resolution of adhesions during fibrinolytic therapy in tetracycline-induced pleural injury in rabbits.

Authors:  Andrey A Komissarov; Galina Florova; Ali O Azghani; Ann Buchanan; William M Bradley; Chris Schaefer; Kathleen Koenig; Steven Idell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-07-10       Impact factor: 5.464

6.  Depressed Kallikrein Generation in Women With Preeclampsia: A Matched Cross-Sectional Study.

Authors:  Anne Cathrine Godtfredsen; Jørgen Brodersen Gram; Stephanie Thuy Duong Pham; Britta Blume Dolleris; Jan Stener Jørgensen; Johannes Jakobsen Sidelmann; Yaseelan Palarasah
Journal:  Front Med (Lausanne)       Date:  2022-06-06

7.  The proteolytic profile of human cancer procoagulant suggests that it promotes cancer metastasis at the level of activation rather than degradation.

Authors:  Nalise Low Ah Kee; Jason Krause; Gregory L Blatch; Koji Muramoto; Kazuo Sakka; Makiko Sakka; Ryno J Naudé; Leona Wagner; Raik Wolf; Jens-Ulrich Rahfeld; Hans-Ulrich Demuth; Wojciech P Mielicki; Carminita L Frost
Journal:  Protein J       Date:  2015-10       Impact factor: 2.371

8.  Activated plasma coagulation β-Factor XII-induced vasoconstriction in rats.

Authors:  Peter C Papageorgiou; Erik L Yeo; Peter H Backx; John S Floras
Journal:  Clin Sci (Lond)       Date:  2012-06       Impact factor: 6.124

9.  Autoimmune Responses to Soluble Aggregates of Amyloidogenic Proteins Involved in Neurodegenerative Diseases: Overlapping Aggregation Prone and Autoimmunogenic regions.

Authors:  Sandeep Kumar; A Mary Thangakani; R Nagarajan; Satish K Singh; D Velmurugan; M Michael Gromiha
Journal:  Sci Rep       Date:  2016-02-29       Impact factor: 4.379

10.  Accelerated fibrinolysis and its propagation on vascular endothelial cells by secreted and retained tPA.

Authors:  Tetsumei Urano; Yuko Suzuki
Journal:  J Biomed Biotechnol       Date:  2012-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.